Fortitude Family Office »

Terns Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.5k 461 7.51
2025-06-30 $1.3k 336 3.73
2023-12-31 $1.9k 300 6.49

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Mid-cap Etf Etf (VO)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares U.s. Technology Etf Etf (IYW)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals